Familial Paroxysmal Dystonic Choreoathetosis & its Differentiation From Related Syndromes
Ann Neurol 2:285, Lance,J.W., 1977
Clinicopathologic Conference, Moyamoya Disease
NEJM 385:2563-2572, Case 40-2021, 2021
Recurrent Involuntary Contractions of the Face, Arm, and Leg in an Elderly Man
JAMA Neurol 76:728-729, Kim, D.D.,et al, 2019
Anti-LG11 Limbic Encephalitis Presenting as an Expanding Insular Lesion
Can J Neuro Sci 46:770-772, Sitwell,L.D.,et al, 2019
Inherited Metabolic Diseases of the Nervous System, Globoid Cell Leukodystrophy (Krabbe Disease, Galactocerebrosidase)
Adams & Victors Principles of Neurology, Chp 37, pg 959, Ropper, A.H.,et al, 2014
Clincopathologic Conference,Graves Disease with Thyrotoxic Periodic Paralysis
NEJM 366:553-560, Case 4-2012, 2012
Transverse Myelitis
NEJM 363:564-572, Frohman,E.M. &Wingerchuk,D.M., 2010
Update on Blepharospasm: Report from the BEBRF International Workshop
Neurol 71:1275-1282, Hallett,M.,et al, 2008
Dystonia
NEJM 355:818-829, Tarsy,D. &Simon,D.K., 2006
Levetiracetam in the Treatment of Idiopathic Hemifacial Spasm
Neurol 62:2134-2135, Deleu,D., 2004
Botulinum Toxin A Treatment for Primary Hemifacial Spasm
Arch Neurol 59:418-420, Defazio,G.,et al, 2002
HIV-Related Movement Disorders, Epidemiology, Pathogenesis and Management
CNS Drugs 16:663-668, Cardoso,F., 2002
Uses of Botulinum Toxin Injection in Medicine Today
BMJ 320:161-165, Munchau,A. & Bhatia,K.P., 2000
An Open-Label Trial of Gabapentin Treatment of Paroxysmal Symptoms in Multiple Sclerosis Patients
Neurol 51:609-611, Solaro,C.,et al, 1998
Long Term Results of Botulinum Toxin Type A (Dysport) in the Treatment of Hemifacial Spasm:A Report of 175 Cases
JNNP 64:751-757, Jitpimolmard,S.,et al, 1998
Hemifacial Spasm:Clinical Findings and Treatment
Muscle & Nerve 21:1740-1747, Wang,A & Jankovic,J, 1998
Tongue Protrusion Dystonia:Treatment with Botulinum Toxin
South Med J 90:522-525, Charles,P.D.,et al, 1997
Botulinum Toxin, Useful in Adult Onset Focal Dystonias
BMJ 305:1169-1170, Lees,A.J., 1992
Treatment of Hemifacial Spasm with Botulinum Toxin
Muscle & Nerve 15:1045-1049992., Yoshimura,D.M.,et al, 1992
Essential Tremor:Clinical Correlates in 350 Patients
Neurol 41:234-238, Lou,J.&Jankovic,J., 1991
Therapeutic Uses Of Botulinum Toxin
NEJM 324:1186-1194, Jankovic,J.&Brin,M.F., 1991
Clinical Use of Botulinum Toxin
National Institutes of Health Consensus Develop Conf Stmt, Nov 12-14, 1990, Arch Neurol 48:1294-1298, 199, 1991
Botulinum Toxin Treatment of Cranial-Cervical Dystonia, Spasmodic Dystonia, Focal Dystonias & Hemifacial Spasm
JNNP 53:633-639, Jankovic,J.,et al, 1990
Assessment:The Clinical Usefulness of Botulinum Toxin-A in Treating Neurologic Disorders
Subcommittee Report, Neurol 40:1332-13361990., , 1990
Hemifacial Spasm in Rochester & Olmsten County, Minnesota, 1960-21984
Arch Neurol 47:1233-1234, Auger,R.G.&Whisnant,J.P., 1990
Blepharospasm, Meige Syndrome, & Hemifacial Spasm:Treatment with Botulinum Toxin
Neurol 35:1499-1500, Mauriello,J.A., 1985
Pathophysiology of Hemifacial Spasm:III, Effects of Facial Nerve Decompression
Neurol 34:891-897, Nielsen,V.K.,et al, 1984
Carbamazepine for Hemifacial Spasm
Neurol 32:286-287, Alexander,G.E.,et al, 1982
Hemifacial Spasm; A Long Term Follow-up of Patients Treated by Posterior Fossa Surgery & Facial Nerve Wrapping
JNNP 44:1100-1103, Kaye,A.H.,et al, 1981
Neurologic Disturbances in Pagets Disease of Bone:Response to Calcitonin
Neurol 29:448-457, Chen,J.R.,et al, 1979
Isaac Syndrome with Laryngeal Involvement:An Unusual Presentation of Myokymia
Neurol 29:1612-1615, Jackson,D.L.,et al, 1979
Hemifacial Spasm
Arch Neurol 35:481, Maroon,J.C., 1978
Polymyalgia Rheumatica
NEJM 394:1097-1109, Dejaco,C.,et al, 2026
Left Atrial Appendage Closure - Another Overused Method in Cardiology?
NEJM 394:1336-1338, Widimsky,P, 2026
Cerebral Amyloid Angiopathy
NEJM 394:1836-1845, Greenberg,S.M., 2026
A 28-Year-Old Man with Seizures and Thalamic Lesions
Neurol 106:e218065, Santos-Rojo,A.B.,et al, 2026
Clinical Presentation, Investigation Findings, and Outcomes of IgG4-Related Pachymeningitis,A Systematic Review
JAMA Neurol 82:193-199, Terrim,S.,et al, 2025
Left Atrial Appendage Closure After Ablation for Atrial Fibrillation
NEJM 392:1277-1287, Wazni,O.M.,et al, 2025
Anticoagulation or Antiplatelet Therapy for Device-Detected Atrial Fibrillation
NEJM 392:1749-1751, Gorey,S., 2025
Upadacitinib - An Up-and-Comer for Treatment of Giant-Cell Arteritis
NEJM 392:2062-2064, Koster,M.J. & Warrington,K.J., 2025
Left Atrial Appendage Occlusion and Its Role in Stroke Prevention
Stroke 56:1928-1937, Seiffge,D.J.,et al, 2025
Collaboration on the Optimal Timing of Anticoagulation after Ischaemic Stroke and Atrial Fibrillation:A Systematic Review and Prospective Individual Participant Data Meta-Analysis of Randomised Controlled Trials (CATALYST)
Lancet 406:43-51, Dehbi,K-M.,et al, 2025
Residual Risk of Recurrent Stroke Despite Anticoagulation in Patients with Atrial Fibrillation,A Systematic Review and Meta-Analysis
JAMA Neurol 82:696-705, McCabe,J.J.,et al, 2025
Pan-Neurofascin Nodo-Paranodopathy Presenting as Fulminant Guillain-Barre Syndrome
Neurol 105:e213848, Cabral,A.,et al, 2025
Cerebral Air Embolism Caused by Atrial-Esophageal Fistula Following Left Atrial Ablation
Stroke 56:e195-e199, Masheyekhi,M.,et al, 2025
Infantile Epileptic Spasms Syndrome (West Syndrome)
Stat Pearls PMID:30725936, Smith,M.S.,et al, 2025
A 66-Year-Old Man with Chronic Orthostatic Hypotension
Neurol 105:e214294, Lenka,A. & Vernino,S, 2025
Patent Foramen Ovale Management for Secondary Stroke Prevention:State-of-the-Art Appraisal of Current Evidence
Stroke 55:236-247, Sposato,L.A.,et al, 2024
Clinicopathologic Conference, Infant Botulism, Case 3-2024
NEJM 390:358-366, Case 3-2024, 2024